Back to UBS Group AG UBS Group AG

OKUROKUR
7 quarters

Position history for UBS Group AGUBS Group AG's holdings in ONKURE THERAPEUTICS INC

UBS Group AG holds 99,604 shares of OKUR (ONKURE THERAPEUTICS INC), worth $454,194 as of 2026-Q2. The position was increased (+2833.8% shares). OKUR represents 0.0% of UBS Group AG's portfolio.

Current Value

$454,194

Current Shares

99,604

Total Value Change

+$435,162

Total Shares Change

+97,391

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
99,604
+2833.8%
$454,1940.0%$4.56
39
2026-Q1
Increased
3,395
+181.0%
$14,0550.0%$2.95
20
2025-Q4
Increased
1,208
+489.3%
$3,5040.0%$2.85
15
2025-Q3
Increased
205
+13.3%
$5640.0%$2.67
9
2025-Q2
Decreased
181
-35.4%
$4330.0%$2.40
0
2025-Q1
Decreased
280
-87.3%
$1,2040.0%$4.46
0
2024-Q4
New
2,213
-
$19,0320.0%$8.27
28

Other major holders of OKUR: RA CAPITAL MANAGEMENT, L.P., CITADEL ADVISORS LLC, BlackRock, Inc., VANGUARD CAPITAL MANAGEMENT LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used